Innovation and technology are at the heart of Air Liquide’s DNA. They have always enabled it to play a pioneering role. Today, these strengths make it possible for the Group to take part in the development of key sectors of the future, such as Healthcare, where its solutions contribute to improving the quality of life of patients. These also include industry and fundamental research where its small molecules are essential to develop the cutting-edge technologies needed to help build a more sustainable society.
That is why, as part of its ADVANCE strategic plan, the Group spends more than 300 million euros per year on research and innovation, with more than half dedicated to the crucial sectors of energy transition and digital technologies.
Our objectives and ambitions |
Our results |
|---|---|
Our objectives and ambitionsOur objectives and ambitions 50%of innovation spending dedicated to the energy transition and to digital technology |
Our results
Our resultsinnovation spending in 2023 of which 51%dedicated to the energy transition and to digital technology |
Our objectives and ambitionsOur objectives and ambitions Improving the quality of life of patientsat home with chronic diseases in mature economies |
Our results
Our resultsMore than 2Mpatients worldwide 55%of patients benefited of personalized care plans in 2023 |